TY - JOUR
T1 - Carbonic anhydrase inhibitors. Part 55. Metal complexes of 1,3,4-thiadiazole-2-sulfonamide derivatives
T2 - In vitro inhibition studies with carbonic anhydrase isozymes I, II and IV
AU - Supuran, Claudiu T.
AU - Scozzafava, Andrea
AU - Briganti, Fabrizio
AU - Ilies, Marc A.
AU - Jitianu, Andrei
PY - 1998
Y1 - 1998
N2 - Coordination compounds of 5-chloroacetamido-1,3,4-thiadiazole-2-sulfonamide (Hcaz) with V(IV), Cr(III), Fe(II), Co(II), Ni(II) and Cu(II) have been prepared and characterized by standard procedures (spectroscopic, magnetic, EPR, thermogravimetric and conductimetric measurements). Some of these compounds showed very good in vitro inhibitory properties against three physiologically relevant carbonic anhydrase (CA) isozymes, i.e., CA I, II, and IV. The differences between these isozymes in susceptibility to inhibition by these metal complexes is discussed in relationship to the characteristic features of their active sites, and is rationalized in terms useful for developing isozyme-specific CA inhibitors.
AB - Coordination compounds of 5-chloroacetamido-1,3,4-thiadiazole-2-sulfonamide (Hcaz) with V(IV), Cr(III), Fe(II), Co(II), Ni(II) and Cu(II) have been prepared and characterized by standard procedures (spectroscopic, magnetic, EPR, thermogravimetric and conductimetric measurements). Some of these compounds showed very good in vitro inhibitory properties against three physiologically relevant carbonic anhydrase (CA) isozymes, i.e., CA I, II, and IV. The differences between these isozymes in susceptibility to inhibition by these metal complexes is discussed in relationship to the characteristic features of their active sites, and is rationalized in terms useful for developing isozyme-specific CA inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=0031779360&partnerID=8YFLogxK
U2 - 10.1155/MBD.1998.103
DO - 10.1155/MBD.1998.103
M3 - Article
AN - SCOPUS:0031779360
SN - 0793-0291
VL - 5
SP - 103
EP - 114
JO - Metal-Based Drugs
JF - Metal-Based Drugs
IS - 2
ER -